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doi:10.1016/j.jtcvs.2004.02.021138 The Journal of Thoracic and CardioObjective: Extrapleural pneumonectomy for therapy of mesothelioma has been
associated with significant perioperative mortality and morbidity. Postoperative
complications of this procedure require a unique management approach. We devel-
oped treatment algorithms for most of the common complications of extrapleural
pneumonectomy resulting in reduced mortality and hospital stay. Complications
after extrapleural pneumonectomy were further analyzed to elucidate means of
prevention, early detection, and treatment.
Methods: A total of 496 patients undergoing extrapleural pneumonectomy were
reviewed for mortality rates, with a subset of 328 consecutive patients between 1980
and 2000 who were examined for detailed morbidity data by using a prospective
clinical database.
Results: Median age was 58 years (range, 28-77 years), with a 10-day (range, 4-101
days) median length of stay. One hundred ninety-eight (60.4%) of 328 patients
experienced minor and major complications, and 11 of 328 patients died, for an
overall mortality rate of 3.4%. Complications included the following: atrial fibril-
lation (145 [44.2%]), prolonged intubation (26 [7.9%]), vocal cord paralysis (22
[6.7%]), deep vein thrombosis (21 [6.4%]), technical complications (patch dehis-
cence, hemorrhage, or both; 20 [6.1%]), tamponade (12 [3.6%]), acute respiratory
distress syndrome (12 [3.6%]), cardiac arrest (10 [3%]), constrictive physiology (9
[2.7%]), aspiration (9 [2.7%]), renal failure (9 [2.7%]), empyema (8 [2.4%]),
tracheostomy (6 [1.8%]), myocardial infarction (5 [1.5%]), pulmonary embolus (5
[1.5%]), and bronchopleural fistula (2 [0.6%]). Clinical data demonstrated the
following: (1) prophylaxis for atrial fibrillation is recommended; (2) early ambula-
tion, aspiration precautions, endoscopic assessment of the vocal cords, and avoid-
ance of fluid overload are crucial; (3) perioperative diagnosis and aggressive
management of deep vein thrombosis are important; (4) immediate reoperation and
open cardiac massage are essential for relief of cardiac herniation and tamponade
from cardiac patch dysfunction; (5) diaphragmatic patch dehiscence, hemorrhage, or
both require immediate reoperation; (6) early signs of infection might indicate
bronchopleural fistula or empyema and should be treated with thoracoscopic or open
vascular Surgery ● July 2004
data have been collected since 1990 throu
Sugarbaker et al General Thoracic Surgerydrainage and staged removal of patch material; and (7) excessive perioperative
mediastinal shift is treated with a catheter placed intraoperatively.
Conclusion: Complications after extrapleural pneumonectomy require a unique
approach to management, and mortality can be minimized by early detection and
aggressive treatment.
G
TSExtrapleural pneumonectomy (EPP) was in-troduced in the 1940s for the treatment ofextensive infections of the lung and pleuralspace, such as tuberculous empyema. Overthe past 20 years, we have applied EPP totreat locally advanced malignant pleural me-
sothelioma (MPM).
Various centers have reported their techniques and re-
sults with EPP, with particular reference to the management
of MPM. In 1976, Butchart and colleagues1 reported their
experience with this operation in patients with mesothelio-
mas and proposed a staging system on the basis of these
results. Although this study remains one of the most quoted
in the literature, an extremely poor operative mortality of
31% was reported. Several other series have since reported
operative results of EPP, with operative mortalities ranging
between 8%2 and 15%.3 In 1999, we reported a series of 183
consecutive patients with MPM who had undergone EPP,
with a mortality rate of 3.8%.4 Since that time, we have
expanded our use of this operation to treat locally advanced
lung cancer and thymoma. Additional refinements in tech-
nique and management have been implemented since 1999,
resulting in still further reductions in operative mortality.
EPP is a technically challenging operation accompanied
by a high rate of perioperative morbidity. Safe outcomes
require a multidisciplinary team approach and skills to
appreciate the significance of early signs of complications.
Our knowledge of the anticipated complications and inter-
ventions to prevent and minimize the effect of these com-
plications has been developed largely through personal ex-
perience. As a result, we currently recognize more
perioperative morbidity, but aggressive intervention has led
to reduced perioperative mortality. The purpose of this
article is to provide a detailed description of the potential
postoperative complications of EPP and our institutional
approach to postoperative management.
Methods
In a retrospective review of medical records at our institution, we
identified patients who underwent EPP between 1980 and 1989 to
supplement a prospective database that was created in 1990. The
retrospective data were collected from medical records from the
1980s when the database was first created in 1990. Prospectivegh patient question-
The Journal of Thoracinaires, as well as visits to the operating rooms, postoperative
wards, and outpatient clinics by our surgical data manager. Insti-
tutional review board approval for the collection of outcome data
in compliance with HIPPA regulations was obtained as early as
1998.
This medical record review revealed that 496 patients had EPP
at the Brigham and Women’s Hospital between 1980 and March
2003. Selection criteria for EPP have not changed since our pre-
vious publication (Table 1).4
Results
From 1980 through 2003, 496 consecutive patients under-
went EPP at the Brigham and Women’s Hospital in Boston.
Of this total, 444 patients underwent EPP for mesothelioma,
28 for stage IIIB adenocarcinoma, 4 for thymoma, and 20
for other diseases. There were 20 deaths within the first 30
postoperative days or within the same hospitalization, for an
overall operative mortality of 4.0%. Pulmonary embolus
was the most common cause of mortality. The 3 patients
who died of unknown causes were from out of state. Al-
though we know they died during the postoperative period,
we are unable to ascertain the exact cause of death (Table
TABLE 1. Patient selection criteria
Patient selection criteria
Karnofsky performance 70
Renal function Creatinine 2
Liver function AST 80 IU/L, total bilirubin
1.9 mg/dL, PT 15 s
Pulmonary function Postoperative FEV1 0.8 L as
per PFTs and quantitative
ventilation-perfusion scans
Cardiac function Grossly normal cardiac function
as per ECG and
echocardiography (EF
preferably 45%)
Extent of disease Limited to ipsilateral hemithorax
with no transdiaphragmatic,
transpericardial, or extensive
chest wall involvement
AST, Aspartate aminotransferase; PT, prothrombin time; FEV1, forced ex-
piratory volume in 1 second; PFTs, pulmonary function tests; ECG, electro-
cardiography; EF, ejection fraction.2).
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TSDetailed morbidity data were accumulated for the first
328 patients with mesotheliomas undergoing operation up
to the year 2000 (Figure 1). Age ranged from 28 to 77 years,
with a median age of 58 years. The overall minor and major
morbidity rate was 60.4%. Median length of stay was 10
days, with a range of 4 to 101 days (Table 3).
Cardiac Complications
Atrial fibrillation (AF) was the most common cardiac and
overall complication in this cohort, with 145 (44.2%) of 328
patients having episodes of AF. Although we have imple-
mented several different prophylactic strategies to address
AF, none has successfully reduced the frequency of this
source of morbidity, and we must await randomized studies
to elucidate an effective prevention regimen in this patient
group.
Other more serious but less common complications in-
clude constrictive physiology caused by inflammatory epi-
carditis (9/328 [2.7%] patients), with 8 patients requiring
reoperation; cardiac tamponade (12/328 [3.6%] patients),
myocardial infarction (5/328 [1.5%] patients); and cardiac
arrest (10/328 [3%] patients).
All cases of constrictive physiology occurred after left
EPP when we did not routinely reconstruct the left pericar-
dium. All patients were symptomatic and had evidence of
constrictive physiology either determined by means of car-
diac catheterization or by means of echocardiography. To
combat this problem, we began to place a patch over the
pericardial defect, even after left EPP, and since using this
practice, we have not encountered a single additional case.
The 8 patients requiring reoperation had inflammatory epi-
carditis as the source of their constrictive physiology.5
Cardiac tamponade physiology can be either the result of
retained pericardial effusion or constrictive patches. Al-
though tamponade arising from pericardial effusion is high
on the list of differential diagnoses, the echocardiographer
should also document the diastolic function of the right
ventricle. A tight or inadequately fenestrated pericardial
TABLE 2. Cause of death
Cause
No. of patients
(n  20/496)
Pulmonary embolus 6
ARDS 4
Myocardial infarction 3
Unknown 3
Cardiac herniation 1
Renal failure 1
Cardiac arrhythmia 1
Heparin-induced
thrombocytopenia
1
ARDS, Acute respiratory distress syndrome.patch can also produce tamponade physiology because of
140 The Journal of Thoracic and Cardiovascular Surgery ● Julythe inability of the ventricle to fill during diastole. Likewise,
a diaphragmatic patch that impinges on the inferior vena
cava, especially when the heart displaces into the right chest
after a right EPP, will produce the same lack of ventricular
filling. An important clue to this condition arises in the
operating room when the patient is turned from the lateral
decubitus to the supine position. A tight patch will result in
persistent hypotension with an increase of the filling pres-
sures (Figure 2). The treatment of choice is to re-explore the
patient and reconstruct the pericardium immediately with a
looser patch. Transesophageal echocardiography can assist
in making the diagnosis before leaving the operating room.
The best treatment is prevention, and a tight patch can be
avoided by beginning the reconstruction in the posterior
pericardium, which tends to be deep, and is thus the most
difficult part of the reconstruction. The posterior pericar-
dium with the sutured patch retracts posteriorly, therefore
permitting better sizing of the patch when it is sutured to the
anterior pericardium. For additional laxity, the inferior bor-
der of the pericardial patch can be sewn to the diaphrag-
TABLE 3. Post-EPP morbidities (n  328)
Age Median, 58 y; range, 28–77 y
Length of stay Median, 10 d; range, 4–101 d
Complications*
Minor and major
morbidity rate
60.4% (198/328)
Atrial fibrillation 44.2% (145/328)
Myocardial infarction 1.5% (5/328)
Constrictive physiology 2.7% (9/328)
Reoperation for
constrictive
physiology
2.4% (8/328)
Tamponade 3.6% (12/328)
Cardiac arrest 3% (10/338)
Prolonged intubation 7.9% (26/328)
Aspiration 2.7% (9/328)
ARDS 3.6% (12/328)
Tracheostomy 1.8% (6/328)
Vocal cord paralysis 6.7% (22/328)
Renal failure 2.7% (9/328)
Deep vein thrombosis 6.4% (21/328)
Pulmonary embolus 1.5% (5/328)
CVA (33 days
postoperative)
0.3% (1/328)
Empyema 2.4% (8/328)
Bronchopleural fistula 0.6% (2/328)
Technical complications
(patch failure and
bleeding)
6.1% (20/328)
Ischemic colitis grade II 0.3% (1/328)
Ileus 0.9% (3/328)
Colectomy for
Clostridium difficile
0.3% (1/328)
ARDS, Acute respiratory distress syndrome; CVA, cardiovascular accident.
*Percentage of patients (n/total).matic patch about 1 cm lateral to the suture line, uniting the
2004
Sugarbaker et al General Thoracic SurgeryFigure 1. Morbidity distribution (%; n  328). AFIB, Atrial fibril-
lation; MI, myocardial infarction; GI, gastrointestinal.
nectomy space to evacuate fluid as needed.Figure 2. A tight pericardial patch can present with hypotension
on turning the patient from the lateral to the supine position. The
surgeon must be present in the operating room when the patient
is being turned because major hemodynamic instability can oc-
cur. TEE, Transesophageal echocardiography.G
TSFigure 3. A pericardial patch that has not been anchored to the
pericardial edge can result in cardiac herniation.
The Journal of ThoraciFigure 4. Excessive mediastinal shift away from the pneumonec-
tomy space into the contralateral hemithorax can result in respi-
ratory compromise. A red rubber catheter is left in the pneumo-Figure 5. Thoracoscopic drainage with full debridement of all
fibrin and pulsed irrigation of the pleural cavity without patch
removal is being used for treatment of early empyema. This is
followed by antibiotic intracavitary irrigation for 5 days.Figure 6. If a Clagett window is deemed necessary, then staged
removal of the prosthetic PTFE patches can prevent overshift of
the mediastinum in the early postoperative period.
c and Cardiovascular Surgery ● Volume 128, Number 1 141
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TSdiaphragmatic patch to the inferior cut edge of the pericar-
dium. Care should also be taken to suture the patch to the
cut edge of the pericardium instead of other weaker tissues
to avoid cardiac herniation (Figure 3).
Although myocardial infarction is rare, pericarditis is
frequently seen in association with diffuse ST-segment in-
creases and high creatine phosphokinase, low MB fraction,
and high troponin levels. These tend to resolve within 48
hours.
Cardiac arrest within 10 days postoperatively requires
emergency thoracotomy (sometimes in the intensive care
unit), open cardiac massage, and pericardial patch removal.
Because the heart has shifted out of the midline, it cannot be
compressed by the sternum and vertebral column, as nor-
mally occurs in closed chest massage. Additionally, emer-
Figure 7. Two patches are used and stapled with a TA stapler,
creating a dynamic patch at the center with less tension at the
sutures that can better accommodate the abdominal contents.
The patch is then tailored to accommodate the mediastinal struc-
tures.
Figure 8. A rim of the diaphragmatic crus is left on the esophagus
and stomach (arrow), which decreases the incidence of gastric
herniation during left EPP.gency thoracotomy permits immediate drainage of un-
142 The Journal of Thoracic and Cardiovascular Surgery ● Julydrained pericardial fluid and compressive fluid within the
operative pleural space, removal of potentially constraining
patches, and reduction of cardiac herniation, which occurs
when the ventricles have herniated through the pericardial
patch and pericardial defect, if present. Typically, the peri-
cardium compresses the ventricular inflow at the atrioven-
tricular groove, causing a sudden and catastrophic reduction
in cardiac output. All members of the postoperative care
team must be educated on this point to avoid losing valuable
time performing futile closed chest compressions. After
successful resuscitation, the patient is immediately returned
Figure 9. Buttons and a small piece of PTFE are used to secure
the patch to the chest wall and prevent the sutures from pulling
through the patch. Sutures are threaded with the use of intrave-
nous angiocatheters and then tied, avoiding excess tension.
Figure 10. Both patches should be sutured to the cut edge of the
pericardium medially and the chest wall anterolaterally and
posteriorly. Failure to do so will result in cardiac or gastric
herniation.to the operating room for pulsed irrigation cleanout of the
2004
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TSchest cavity and surgical correction of the cause of the
cardiac arrest.
Pulmonary Complications
Pulmonary complications include prolonged intubation (26/
328 [7.9%] patients), aspiration (9/328 [2.7%] patients),
acute respiratory distress syndrome (ARDS; 12/328 [3.6%]
patients), and the need for tracheostomy (6/328 [1.8%]
patients). These complications are closely associated with
vocal cord paralysis, which occurred in 22 (6.7%) of 328
patients.
A high index of suspicion is needed to diagnose and treat
vocal cord paralysis. Patients who had extensive disease
resected in high-risk areas for recurrent nerve injury (ie,
aortopulmonary region and the subclavian vessels) are
scoped postoperatively, even in the absence of symptoms
such as a hoarse voice or poor cough. Vocal cord weakness
places the patient at high risk for aspiration after pneumo-
nectomy, which is frequently life-threatening. Therefore we
recommend immediate injection of the vocal cords with gel
foam when the condition is diagnosed.6
Aggressive diuresis postoperatively is essential to avoid
pulmonary edema, and liberal use of bronchoscopy is
needed to clear retained secretions.
Excessive mediastinal shift away from the pneumonec-
tomy space into the contralateral hemithorax can result in
decreased lung volume, retained secretions, and respiratory
compromise. A red rubber catheter is left in the pneumo-
nectomy space for 3 days, and fluid is evacuated as needed
to ensure a midline mediastinum and contralateral lung
expansion (Figure 4).
Renal, Hematologic, and Infectious Complications
Renal failure was seen in 9 (2.7%) of 328 patients and is
generally associated with ARDS, multiple organ failure, and
death.
Deep vein thrombosis was recognized in 21 (6.4%) of
328 patients, with 5 (1.5%) of 328 patients having pulmo-
nary embolism. Because a pulmonary embolus to a single
remaining lung is always life-threatening, we have adopted
an aggressive screening protocol, obtaining noninvasive
vascular studies on all patients during the seventh postop-
erative day. We have a low threshold for using pulmonary
embolus computed tomographic scans in patients with mod-
erate symptoms or minor oxygen desaturations and have
recently been diagnosing pulmonary emboli with a greater
frequency.
Postoperative empyema has been unusual (8/328 [2.4%]
patients) in our experience. Infection in a chest with 2
prosthetic grafts can be catastrophic. Clinical signs of in-
fection are often lacking and cultures may fail to detect
anaerobic infection. Our prevention regimen includes
pulsed irrigation of the pneumonectomy cavity with a high-
The Journal of Thoracipressure 9-L lavage intraoperatively. We use a small, red
rubber catheter placed through the wound rather than stan-
dard-size chest tube placement through a separate incision
to reduce potential contamination along the outside of the
catheter. A triple intravenous antibiotic regimen, including
cefazolin (Ancef; Smith Kline Beecham, Philadelphia, Pa),
levofloxacin (Levaquin; Ortho-McNeil, Raritan, NJ), and
metronidazole (Flagyl; Searle, Skokie, Ill), is used for 5
days perioperatively because prosthetic materials are used
for the pericardial and diaphragmatic reconstruction.
When empyema does occur, management is dependent
on the time of presentation. Patch removal and a traditional
Clagett window will delay adjuvant chemoradiation ther-
apy. Open chest management complicated by tumor recur-
rence is a dreaded complication. We have successfully used
thoracoscopically guided closed chest management with full
debridement of all fibrin and pulsed irrigation of the pleural
cavity without patch removal.7 This is followed by postop-
erative irrigation for 5 days (Figure 5). The closed approach
for postoperative empyemas was successful in 3 of the 4
patients who underwent this procedure. This technique is
applied to patients who have empyema without broncho-
pleural fistulas during the first postoperative month. Patients
who have empyema months to years after resection are
usually managed with Clagett windows because they tend to
present later in the course of their disease. If a Clagett
window is deemed necessary because of the amount of
infection, staged removal of the prosthetic polytetrafluoro-
ethylene (PTFE) patches (Gore-Tex; W. L. Gore & Asso-
ciates, Inc, Flagstaff, Ariz) can prevent overshift of the
mediastinum (Figure 6). Removal of the patches before
mediastinal stabilization will result in hemodynamic com-
promise. The staged removal of the PTFE patch is used for
patients who present early (ie, in the first 2 weeks, before
the mediastinum has become scarred in) with empyema that
is deemed unmanageable with thoracoscopic lavage or is
complicated with bronchopleural fistulas. The Clagett win-
dow is created, leaving the patches in place. After 2 to 3
weeks of dressing changes, the mediastinum is sufficiently
scarred to permit the patches to be removed. In our practice
we tend to reserve this procedure for patients with broncho-
pleural fistulas. It is such a rare complication during the
early postoperative period that we do not have an extensive
experience or comparison between the various approaches
to this complication.
The presence of a bronchopleural fistula necessitates
drainage of the cavity with a Clagett window to protect the
contralateral lung. This has only occurred twice in our
experience (0.6%).
Technical Complications
Our pericardial and diaphragmatic reconstructions have un-
dergone constant evolution over the last 15 years. Our
c and Cardiovascular Surgery ● Volume 128, Number 1 143
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patch, 0.1 mm for the pericardium and 2 mm for the dia-
phragm. The impermeable diaphragm patch prevents excess
fluid accumulation in the chest. Two patches are used and
stapled with a TA stapler (proximate TX linear stapler,
Ethicon, Inc, Somerville, NJ), creating a dynamic patch at
the center with less tension at the sutures. The patch is then
tailored to accommodate the mediastinal structures (Figure
7).
A rim of the diaphragmatic crus is left on the esophagus
and stomach, decreasing the incidence of gastric herniation
(Figure 8).
The patch should be sutured to the cut edge of the
pericardium medially and the chest wall anterolaterally and
posteriorly (Figure 9). The patch should be loose because a
tight patch will predispose to herniation. Daily chest x-ray
films should be compared with the initial postoperative film.
The mere suggestion of gastric or bowel herniation with
complex gas patterns in the operative hemithorax should be
rapidly assessed by means of computed tomographic scan-
ning, and reoperation should occur as soon as it is recog-
nized to avoid ischemic perforation and spillage of the
bowel contents.
The method of securing the patch to the chest wall was
developed in response to oncologic and technical issues.
Bulky tumors necessitate resection of the entire diaphragm,
leaving only a small rim of the diaphragm that is insufficient
for securing the patch. We have no oncologic data to com-
pare diaphragmatic resection techniques.
In addition, the diaphragmatic reconstruction technique
was adjusted from the previous single-patch technique to
the current double-patch technique as a consequence of
concerns about gastric herniation. Patients with ileus seem
to be particularly at risk because of increased intra-abdom-
inal pressure and tension on the patch. The 2-patch method
was used in an attempt to recreate the dome shape of the
diaphragm. We have no laboratory data to support the
superiority of the 2-patch technique. However, when we
compared 2 groups of consecutive patients, the patch dehis-
cence incidence of 6 (12%) of 50 with the old technique was
reduced to 1 (3.8%) of 26 with the 2-patch technique.
As stated previously, the pericardial patch is used for
both right and left reconstructions to avoid the development
of constrictive physiology. The pericardial patch should
always be sutured to the pericardium because other tissues
will not hold, and cardiac herniation might result in cardiac
arrest (Figure 10).
Meticulous hemostasis is crucial because excessive
bleeding can also result in mediastinal shift. Chylothorax
remains rare, but an excessive rate of fluid accumulation in
the pneumonectomy cavity can be an important clue. Treat-
ment can now be facilitated with percutaneous emboliza-
tion.
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The previous experience with EPP for mesothelioma re-
ported by Butchart and colleagues1 was accompanied by an
almost prohibitive mortality rate. The modern experience
with EPP as a treatment for locally advanced cancer began
in the 1980s, with reported mortality rates ranging from 6%8
to 15%.3 Mortality rates have continued to decrease in the
1990s, with some authors reporting up to a 50% reduction
over previous mortality rates at their institutions.4,9 The
Brigham strategy has been to continuously refine the surgi-
cal technique and to prevent and aggressively seek out
complications at an early stage, when they are easier to treat
and their physiologic effect on this tenuous group of pa-
tients remains minimal. This strategy has permitted the
expansion of operative criteria to include patients who a few
years ago would have been deemed inoperable.
The diaphragmatic and pericardial reconstructions are
crucial to avoiding gastric and cardiac herniation. Our ag-
gressive screening for vocal cord paralysis, thrombotic
complications, and liberal use of bronchoscopy has helped a
great deal in achieving low mortality rates because ARDS
and cardiovascular complications, such as pulmonary em-
bolus, remain the leading causes of death. The management
of empyema and cardiac arrest is unique in these patients.
Most of these strategies remain empiric in nature. One
could draw conclusions from randomized studies; however,
the relatively small group of patients undergoing EPP every
year compared with the number of patients undergoing
lobectomies for lung cancer, for example, does not permit
randomized studies to be conducted for testing these strat-
egies.
This review represents our institution’s 20-year experi-
ence from 1980 through 2000 and demonstrates the constant
evolution of our operative technique, which has resulted in
a steady reduction in postoperative mortality. The operative
procedure discussed here demands intraoperative and post-
operative vigilance from the care team for early signs of
complications. The knowledge we have accumulated over
the last 20 years re-enforces the view that a multidisci-
plinary approach remains crucial in the perioperative pe-
riod.
References
1. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumo-
nectomy in the management of diffuse malignant mesothelioma of the
pleura. Experience with 29 patients. Thorax. 1976;31(1):15-24.
2. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma.
Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North
Am. 1994;4(1):113-26.
3. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneu-
monectomy in malignant pleural mesothelioma. A Lung Cancer Study
Group trial. J Thorac Cardiovasc Surg. 1991;102(1):1-9.
4. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM,
Corson JM, et al. Resection margins, extrapleural nodal status, and cell
type determine postoperative long-term survival in trimodality therapy
2004
Sugarbaker et al General Thoracic Surgery
G
TSof malignant pleural mesothelioma: results in 183 patients. J Thorac
Cardiovasc Surg. 1999;117(1):54-65.
5. Byrne JG, Karavas AN, Colson YL, Bueno R, Richards WG, Sugar-
baker DJ, et al. Cardiac decortication (epicardiectomy) for occult con-
strictive cardiac physiology after left extrapleural pneumonectomy.
Chest. 2002;122(6):2256-9.
6. Bhattacharyya N, Batirel H, Swanson SJ. Improved outcomes with early
vocal fold medialization for vocal fold paralysis after thoracic surgery.
Auris Nasus Larynx. 2003;30(1):71-5.
7. Hollaus PH, Lax F, Wurnig PN, Janakiev D, Pridun NS. Videothora-
coscopic debridement of the postpneumonectomy space in empyema.
Eur J Cardiothorac Surg. 1999;16(3):283-6.
8. Sugarbaker DJ, Mentzer SJ, Strauss G. Extrapleural pneumonectomy in
the treatment of malignant pleural mesothelioma. Ann Thorac Surg.
1992;54(5):941-6.
9. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison
L, et al. A phase II trial of surgical resection and adjuvant high-dose
hemithoracic radiation for malignant pleural mesothelioma. J Thorac
Cardiovasc Surg. 2001;122(4):788-95.
Discussion
Dr Daniel L. Miller (Atlanta, Ga). Dr Sugarbaker, I would like to
congratulate you on an excellent presentation and also congratulate
you and your colleagues at the Brigham for compiling the largest
series of EPPs in the world. Your hard work and refinement of the
technique of EPP has allowed this procedure to be put back into
the armamentarium of thoracic surgeons so we can help to improve
the long-term survival of patients with mesotheliomas.
I have several questions for you. Although more than 60% of
your patients experience a minor or major complication after EPP,
your overall operative mortality rate was less than 4%. What do
you believe has been the single most important factor that has
reduced your operative mortality: selection, operative technique,
postoperative care? Probably it is going to be the combination of
the 3, but what do you believe has been the most important?
Dr Sugarbaker. Thanks very much. I would say that reduction
in operative time through the years probably has had a large effect
on getting these patients in and out of the hospital. Selection has
also been very, very important with the use of magnetic resonance
imaging and echocardiography preoperatively—everybody gets an
echocardiogram. And we have detected some previously undetec-
ted myocardial dysfunction that would have led to, I think, post-
operative complications. But I would say the most important factor
has been the reduction in operative time from an average of about
6 1⁄2 hours to slightly less than 3 hours now from beginning to end.
Dr Miller. Your incidence of postoperative empyema and
bronchopleural fistula was extremely low at 2.4% and 0.6%, re-
spectively. Could you comment again on your technique for bron-
chial reinforcement, which you did not bring up during the talk,
and also again about your technique of drainage of the pleural
cavity. I know that you have switched to a red rubber catheter.
Why did you do that? Also, please discuss again the pulsed
irrigation of the chest, which I think is new to a lot of us in the
audience.
Dr Sugarbaker. I will start with the reinforcement of the
stump. I think the most important thing is, particularly on the left,
to have a short stump so that you do not have dependent secretions.
We use a parathymic-pericardial fat pad based on a proximal
pedicle to cover each stump and suture it in place with 3.0 Vicryl
sutures. I think that is a very, very important component. I know
there is some disagreement from some others who do this proce-
dure, but we believe it is part of the overall plan.
The Journal of ThoraciThe red rubber catheter is a large no. 9 catheter. It is brought
out through the wound, through a little Christmas tree and a
stopcock. That should initially balance the chest and have the
ability to remove fluid. And I would say one of the things that has
also gone down is that we do not reoperate for bleeding as much
as we used to. We just keep aspirating fluid, and the patients do
eventually stop bleeding if they have a bleeding problem, although
that has also, I think, gone down quite a bit with reduction in
operative time. Therefore the red rubber catheter, I think, is a very
nice little instrument to have there. It is diagnostic, it is therapeutic,
and it comes out easily at about 3 days. The pulsed irrigator is
simply the Water Pik irrigator. You have probably seen orthope-
dists do this for hips. We use a combination of sterile water and
Betadine solution, and, as mentioned in the article, do a 6-L lavage
at the end of the procedure. It has helped, I think, to reduce not
only our bacteriologic contamination but also cytologic contami-
nation of the wound.
Dr Miller. The data analysis that you included in this study was
through 2000. What effects has the addition of hyperthermic
pleural lavage had on your complication rate, especially in regard
to pleural space problems and deep venous thrombosis?
Dr Sugarbaker. That is an excellent insight. Our AF rate has
gone to 80%. When you lavage the heart with hyperthermic
cisplatinum at a high dose, it is irritating, and most patients have
gone into AF, which is pushing us to explore some other means of
prophylaxis against that. The other major complication is a 24%
deep vein thrombosis rate, which, as you mentioned, I think is
probably from the hyperthermic effect on the coagulation system
with the blood heating up. The core temperatures do get up there
to around 41°C.
Dr Miller. Because of your high morbidity rate and so forth,
you have always talked about trimodality therapy being very
important. Because of this high morbidity rate, what percentage of
your patients completes all 3 modalities?
Dr Sugarbaker. That is a good question. The data are that
about 80% of patients received adjuvant therapy. Now, much of it
is done back home. Two cycles, 1 cycle, 3 cycles; it is sometimes
hard to get your hands around that data, so that is why I have not
presented it.
Dr W. Roy Smythe (Houston, Tex). Dr Sugarbaker, we en-
joyed your article and your teaching, and there is no doubt that
those of us who have been doing this for the last 5 or 10 years are
standing squarely on your shoulders, and we really appreciate all
of your hard work.
Dr Sugarbaker. Thank you.
Dr Smythe. I have 2 brief questions. One, have you stratified
these morbidities by stage, either your staging system or the new
AJCC? Second, in addition to using electrocautery and the argon
beam, have you considered using any pharmacologic intervention?
Of course, with your recent experience with the deep vein throm-
boses, this might sound a little scary, but we have been using
aprotinin for about the last 40 or 50 patients and have seen a
significant decrease in blood product use, which we think trans-
lates to a lower pulmonary complication profile.
Dr Sugarbaker. I thank you very much for your kind com-
ments. Let me start with your last question. We have looked at
several pharmacologic ways in which we might improve and
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TSreduce blood loss, but we do have this problem now, particularly
with the hyperthermic patients, of deep vein thromboses and a
pulmonary embolism rate that is apparently going up. Therefore I
think we are going to approach that with some trepidation.
Your other question I do not have an answer for, and that is, is
there a staged distribution. The majority of patients are stage I or
stage II by the Brigham staging system with N1 disease or N0
disease. The majority do not have N2 disease. Extrathoracic node
positivity runs about 25%. But I do not have a stratification of this
morbidity, which is primarily reversible. I mean, most of it was
AF, which is reversible, but there is no question that it is signifi-
cant.
Dr Raja M. Flores (New York, NY). I have a comment on
pericardial reconstruction and a question. At our institution, we use
Dexon mesh for several reasons for the pericardial reconstruction.
One is that there is no need for fenestration; it is already porous.
The other is that it has more give than PTFE, so when the heart
146 The Journal of Thoracic and Cardiovascular Surgery ● Julybecomes edematous, especially after intraoperative chemotherapy,
there is more give and less chance of cardiac constriction. Third
and most importantly is that it is absorbable, and therefore in the
event of empyema, there is no need to pull the PTFE off of an
already friable myocardium.
My question is with regard to AF prophylaxis. Have you started
yet, and have you come into any problems? These patients are
already hemodynamically unstable, they have an epidural catheter
in, there is already potential for bleeding, and then when you add
on to that calcium channel blockers or -blockers, I would antic-
ipate problems with hemodynamics.
Dr Sugarbaker. Thank you very much for your comments, Dr
Flores. In terms of the pericardial reconstruction, that is an inter-
esting concept to use an absorbable patch. The low incidence of
empyema makes it sort of less of an issue in terms of removing the
PTFE, which, as you know, cannot be wetted and usually comes
off the heart without too much difficulty.
2004
